Suchergebnisse - "Tan, Qiaoyun"

PubPharm (31)

21

Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy

enthalten in: Cancer immunology immunotherapy | 2021

von Tan, Q. | Dai, L. | Wang, Y. | +20

22

SLF1 polymorphism predicts response to oxaliplatin-based adjuvant chemotherapy in patients with colon cancer

enthalten in: American journal of cancer research | 2021

von Han, X. | Wang, Z. | Zhang, L. | +7

23

Anti-p53 autoantibody in blood as a diagnostic biomarker for colorectal cancer : A meta-analysis

enthalten in: Scandinavian journal of immunology | 2020

von Liu, S. | Tan, Q. | Song, Y. | +2

24

Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patients

enthalten in: Theranostics | 2020

von Tan, Q. | Wang, D. | Yang, J. | +24

25

Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapy

enthalten in: Journal of translational medicine | 2019

von Han, X. | Han, Y. | Tan, Q. | +12

26

Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapy

enthalten in: Journal of translational medicine | 2019

von Han, X. | Han, Y. | Tan, Q. | +12

27

Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapy

enthalten in: Journal of translational medicine | 2019

von Han, X. | Han, Y. | Tan, Q. | +12

28

Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I-III Lung Adenocarcinoma

enthalten in: Frontiers in oncology | 2019

von Han, X. | Tan, Q. | Yang, S. | +16

29

CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK

enthalten in: Current cancer drug targets | 2019

von Liang, C. | Zhang, N. | Tan, Q. | +5

30

CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK

enthalten in: Current cancer drug targets | 2019

von Liang, C. | Zhang, N. | Tan, Q. | +5